Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin nanoparticles in smart hydrogel for endodontic infections
NCT05442736Phase 1Completed
- Sponsor
- The British University in Egypt
- Start
- Apr 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ciprofloxacin + ibuprofen gel in Endodontic infection, sponsored by The British University in Egypt. Primary endpoint: Infection inhibition at 2 weeks. Started Apr 2022; status: completed.
02
Drugs
ciprofloxacin + ibuprofen gel
03
Conditions
Endodontic infection
Beyond the preview
Go deeper on NCT05442736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05442736.